HW
VIVO

Hancock Whitney’s Meridian Bioscience Inc VIVO Stock Holding History

Hancock Whitney’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,711
Closed -$521K – 666
2022
Q4 		$521K Sell
15,711
-139
-0.9% -$4.48K 0.02% 424
2022
Q3 		$500K Sell
15,850
-606
-4% -$19.6K 0.02% 417
2022
Q2 		$500K Buy
16,456
+12
+0.1% +$325 0.02% 419
2022
Q1 		$427K Buy
16,444
+143
+0.9% +$3.4K 0.01% 505
2021
Q4 		$334K Sell
16,301
-1,086
-6% -$20.8K 0.01% 566
2021
Q3 		$334K Sell
17,387
-29,850
-63% -$595K 0.01% 551
2021
Q2 		$1.05M Buy
47,237
+387
+0.8% +$8.21K 0.03% 394
2021
Q1 		$1.23M Buy
46,850
+22,833
+95% +$543K 0.04% 369
2020
Q4 		$449K Buy
24,017
+646
+3% +$12.1K 0.02% 552
2020
Q3 		$397K Buy
+23,371
New +$454K 0.01% 569
2019
Q1 		– Sell
-82,653
Closed -$1.44M – 883
2018
Q4 		$1.44M Sell
82,653
-7,504
-8% -$128K 0.05% 364
2018
Q3 		$1.34M Sell
90,157
-3,936
-4% -$61K 0.04% 423
2018
Q2 		$1.5M Buy
94,093
+6,365
+7% +$94.9K 0.07% 259
2018
Q1 		$1.25M Buy
87,728
+40,246
+85% +$596K 0.06% 309
2017
Q4 		$665K Sell
47,482
-28,915
-38% -$423K 0.03% 405
2017
Q3 		$1.09M Buy
76,397
+11,143
+17% +$159K 0.05% 329
2017
Q2 		$1.03M Buy
65,254
+10,171
+18% +$147K 0.04% 334
2017
Q1 		$760K Buy
55,083
+15,384
+39% +$215K 0.03% 388
2016
Q4 		$703K Sell
39,699
-3,246
-8% -$57K 0.03% 423
2016
Q3 		$828K Buy
42,945
+2,279
+6% +$44.6K 0.03% 392
2016
Q2 		$793K Sell
40,666
-36,728
-47% -$720K 0.03% 384
2016
Q1 		$1.59K Buy
77,394
+7,866
+11% +$155K 0.07% 265
2015
Q4 		$1.43M Buy
69,528
+34,266
+97% +$657K 0.06% 275
2015
Q3 		$603K Buy
+35,262
New +$644K 0.03% 411

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hancock Whitney's VIVO Position: Q1 2023 in Review

Hancock Whitney sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 15,711 shares — an estimated $521K sold.

Hancock Whitney first reported a position in VIVO in Q3 2015 and held it in 24 quarters. The position peaked at $1.5M in Q2 2018. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • Hancock Whitney reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • Hancock Whitney sold 15,711 Meridian Bioscience Inc shares in Q1 2023, an estimated $521K.
  • Hancock Whitney first reported a position in Meridian Bioscience Inc in Q3 2015 and held it in 24 quarters.
  • Hancock Whitney's Meridian Bioscience Inc position peaked at $1.5M in Q2 2018.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Hancock Whitney's 13F filing for Q1 2023, filed 15 May 2023.